(Q41396602)

30 September 2017

1 reference

title

Cytogenetics and molecular genetics in multiple myeloma (English)

1 reference

30 September 2017

1 reference

Feinman R

1

1 reference

30 September 2017

Sawyer J

series ordinal

2

1 reference

30 September 2017

Hardin J

series ordinal

3

1 reference

30 September 2017

Tricot G

series ordinal

4

1 reference

30 September 2017

1 February 1997

1 reference

Hematology / Oncology Clinics of North America

30 September 2017

1 reference

30 September 2017

11

1 reference

30 September 2017

1-25

1 reference

30 September 2017

1

1 reference

Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The GTPase superfamily: conserved structure and molecular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The oncoprotein phenotype of plasma cells from patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Regulatory mechanisms for ras proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The many roads that lead to Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

E2F-1 functions in mice to promote apoptosis and suppress proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Inhibition of apoptosis by the retinoblastoma gene product.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Apoptosis: molecular regulation of cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Effects of an Rb mutation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The Ras signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Interleukin-6 inhibits apoptosis of malignant plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Analysis of RAS oncogene mutations in human lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Myc oncogenes: the enigmatic family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Cytogenetic findings in 200 patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Karyotype in multiple myeloma and plasma cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Tumor induction and tissue atrophy in mice lacking E2F-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

N-ras and p53 gene mutations are very rare events in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Multiple myeloma: almost all patients are cytogenetically abnormal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970412-3

7 January 2021

10.1016/S0889-8588(05)70412-3

Identifiers

DOI

1 reference

30 September 2017

1 reference